Nandini Rudra-Ganguly
Associate Director, Precision Medicine Oncology Abbvie
Seminars
Tuesday 4th November 2025
Understanding the Potential of Emerging Technologies to Identify Target ADC Patients
3:00 pm
- Exploring applications of liquid biopsies and ctDNA in the development and characterization of ADCs
- Understanding how liquid biopsies can be used in early clinical development, such as informing dose selection
- Applying lessons learned to ongoing and future ADCs
